Close Menu

financial results

Overall growth was driven by the company's diagnostics segment, which rose 11 percent, while life sciences improved 6 percent

The company also announced a diagnostic laboratory service partnership with Montefiore Health System.

Separately, Alere said today that the European Commission has granted clearance for its acquistion by Abbott.

The firm said that it is on track to seek FDA approval for a liquid cytology solution early this year.

The company made changes to its reporting segments "to reflect how management strategically thinks about the business categories."

FilmArray drove business growth in molecular biology, contributing €80 million to Q4 revenues and €249 million to FY 2016 revenues. 

The firm expects full-year revenue growth of up to 39 percent, but fell short of prior guidance for the year.

The firm also reported that full-year 2016 revenues grew 25 percent over 2015, driven in part by strong ePlex instrument sales.

The infectious disease diagnostics firm secured eight new contracts covering 18 hospital in the US and Europe during the fourth quarter.

The firm also reported that 2016 preliminary revenues were up 14 percent, and that Nanosphere MDx platform revenues rose 32 percent.